Studies | Number of isolates | Antimicrobials resistance rate reported by 12 studies (%) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P | AMP | AML | E | STR | T | NA | CF | GM | CIP | CL | A/C | DC | NOR | CRO | T/S | CD | K | ||
Lengerh et al. [13] | 44 | – | 68.2 | – | 27.7 | – | 56.8 | 9.1 | 88.9 | 18.2 | 16 | 11.4 | 36.4 | 15.9 | 11.6 | 27.7 | 54.5 | 40.9 | – |
Beyene et al. [21] | 50 | – | 50 | – | 10 | – | 14 | – | – | 0 | – | 0 | – | – | – | – | 60 | – | 0 |
Dadi et al. [10] | 50 | – | 10 | 6 | 2 | 20 | 10 | – | – | 14 | – | 4 | – | – | – | – | – | – | 12 |
Kebede et al. [27] | 13 | – | – | – | 23.1 | – | 23.1 | 7.7 | – | 0 | 7.7 | 53.8 | – | – | 0 | 0 | 61.5 | – | – |
Getamesay et al. [28] | 20 | – | 30 | 80 | 55 | – | 15 | 20 | 70 | 70 | 10 | 0 | – | – | – | 0 | 20 | – | – |
Chanyalew et al. [25] | 48 | – | 33.3 | – | – | 4.2 | 20.8 | 2.1 | 100 | – | – | – | – | – | – | – | – | – | – |
Tafa et al. [24] | 38 | – | 76 | – | 18.4 | – | 39.5 | 10.5 | 100 | 13.2 | 15.8 | 31.6 | – | 23.7 | 10.5 | – | 68.4 | 26.3 | – |
Ewnetu et al. [11] | 15 | – | 18.8 | – | 18.8 | 25 | 22.2 | 12.5 | – | – | – | – | – | – | – | – | – | – | – |
160 | – | 34.1 | – | 14.9 | 20.5 | 30.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
Kassa et al. [22] | 192 | – | 19.8 | – | 2.6 | 6.3 | 2.6 | 6.3 | 96.9 | 0.5 | – | – | – | – | 2.2 | – | 38.5 | 2.1 | – |
Abamecha et al. [29] | 208 | – | 38.9 | – | 50.5 | – | 69.2 | 3.8 | 100 | – | 71.2 | 51.4 | – | – | 54.3 | – | – | 45.7 | – |
Nigatu et al. [26] | 84 | 100 | 8.3 | – | 60 | 13.1 | 35.7 | 0 | 40.5 | – | – | – | – | – | – | – | – | – | – |